Nirav Shah to Receptors, Antigen, T-Cell
This is a "connection" page, showing publications Nirav Shah has written about Receptors, Antigen, T-Cell.
Connection Strength
0.297
-
Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells. Am J Hematol. 2022 12; 97(12):1580-1588.
Score: 0.159
-
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial. Nat Med. 2020 10; 26(10):1569-1575.
Score: 0.139